The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Amazon, Berkshire, JPMorgan Partner to Cut U.S. Healthcare Costs

Amazon, Berkshire, JPMorgan Partner to Cut U.S. Healthcare Costs

January 30, 2018 • By Caroline Humer & David Henry

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters)—Amazon.com Inc., Berkshire Hathaway Inc. and JPMorgan Chase & Co. said on Tuesday they will form a company to cut health costs for hundreds of thousands of their employees, setting up a major challenge to an inefficient U.S. healthcare system.

You Might Also Like
  • Walgreens & Microsoft Partner to Develop Digital Healthcare Services
  • Fed Up with Rising Costs, Big U.S. Firms Dig Into Healthcare
  • Health Insurer Cigna to Buy Express Scripts for about $54 Billion

The move by three of the best-known U.S. business leaders—Amazon’s Jeff Bezos, Berkshire’s Warren Buffett and JPMorgan’s Jamie Dimon—would take on the world’s most expensive healthcare system, whose mounting costs have hurt corporate profit. Shares of U.S. healthcare companies fell across the board.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The new, not-for-profit venture will initially focus on technology for “simplified, high-quality and transparent healthcare” for their more than 500,000 U.S. employees, the companies said. They did not elaborate on their strategy, but said they are searching for a chief executive officer.

Healthcare industry experts say the new entity could eventually negotiate directly with drugmakers, doctors and hospitals and use their vast databases to get a better handle on the costs of those services.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

That could undercut the industry’s middlemen, from health insurers to pharmacies and benefits managers.

“The ballooning costs of healthcare act as a hungry tapeworm on the American economy,” said Berkshire Hathaway Chairman and CEO Buffett. “Our group does not come to this problem with answers. But we also do not accept it as inevitable.”

U.S. healthcare spending has been increasing annually faster than inflation, and in 2017 accounted for 18% of the economy. Corporations sponsor health benefits for more than 160 million Americans.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“There are a lot of companies, or arguably almost all companies, in healthcare that benefit from cost inflation running as high as it has been for many years,” ISI Evercore analyst Michael Newshal said. “And if there is pressure to lower that, that can flow throughout the entire system.”

Starting the Conversation
The new initiative grew out of conversations that Bezos, Buffett and Dimon have held over the years and gained momentum in recent months, according to a person involved with the consortium but who was not authorized to speak publicly.

The three CEOs plan for their companies to be the only clients of the joint venture, the person said. However, they intend to share the strategies and technology they ultimately develop to reduce costs for the economy and the government.

Traditional healthcare players have tried to reduce costs without losing their profit margins. Most recently, pharmacy network CVS Health Corp reached a $69 billion deal to buy insurer Aetna Inc., arguing their combination could save money for the nation’s employers.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: Health Insurance, Healthcare, healthcare cost

You Might Also Like:
  • Walgreens & Microsoft Partner to Develop Digital Healthcare Services
  • Fed Up with Rising Costs, Big U.S. Firms Dig Into Healthcare
  • Health Insurer Cigna to Buy Express Scripts for about $54 Billion
  • FDA’s Gottlieb Blames Industry ‘Kabuki Drug Pricing’ for High Costs

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.